Venetoclax | CAS 1257044-40-8 - Request Quote
Venetoclax
| SZ CAT No: | SZ-V022001 |
| CAS No | 1257044-40-8 |
| Mol.F. | C45H50ClN7O7S |
| Mol.Wt. | 868.5 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Venetoclax is chemically 4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide. Venetoclax is supplied with detailed characterization data compliant with regulatory guideline. Venetoclax can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Venetoclax.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1257044-40-8
Purchase 1257044-40-8
Order 1257044-40-8
Enquire 1257044-40-8
price of 1257044-40-8
1257044-40-8 Supplier
1257044-40-8 Manufacturer
1257044-40-8 Exporter
buy high quality Venetoclax
Purchase Venetoclax
Venetoclax suppliers
Venetoclax manufacturers
Venetoclax price
Order Venetoclax
Enquire Venetoclax
Venetoclax cost
Venetoclax Supplier
Venetoclax Distributor
Venetoclax for Method Validation
Venetoclax Reference Standard
Venetoclax for ANDA Filing
Venetoclax for Forced Degradation Studies
Venetoclax Identification Standards
Venetoclax for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


